Expression of “non-classical” molecules of the main histocompatibility complex in rheumatoid arthritis and bronchial asthma

Cover Page

Cite item

Full Text

Abstract

HLA-E is a minor understudied non-classical HLA genes. HLA-E transcription is revealed in many cell types, especially, in immune cells, e.g., T and B cells monocytes, macrophages. In this work, we evaluated expression of HLA-E on CD8+, CD4+ and CD14+ cells in conditionallу healthy donors and in the patients with bronchial asthma (BA) and rheumatoid arthritis (RA). Peripheral blood mononuclears (PBMNC) were used as initial biomaterial. PBMNC from RA patients (n = 15), BA (n = 11) and healthy donors were separated from peripheral blood in Ficoll-Urographin density gradient (1.077 g/mL). The cells were then stained with fluorochrome-conjugated monoclonal antibodies: anti-CD3-APC, anti-CD4-APC-Cy7, anti-CD-14-FITC, and anti-HLA-E-PerCP/Cy5. The cell phenotype was analyzed by flow cytometry with FACS Canto II (BD Biosciences, USA). We have found an increased expression of HLA-E on CD8+, CD4+Т cells, like as on CD14+ cells (monocytes) in the RA patients, when compared with BA patients. We have also shown significant differences of HLA-E expression on CD8+Т cells between the conditionally healthy donors and RA patients.

About the authors

Olga S. Boeva

Research Institute of Fundamental and Clinical Immunology; Novosibirsk State University

Author for correspondence.
Email: starchenkova97@gmail.com

Student, Novosibirsk State University; Assistant Researcher, Laboratory of Clinical Immunopathology, Research Institute of Fundamental and Clinical Immunology

Russian Federation, Novosibirsk; Novosibirsk

V. I. Borisevich

Novosibirsk State Medical University

Email: borvad2001@mail.ru

Student, Novosibirsk State Medical University

Russian Federation, Novosibirsk

V. A. Kozlov

Research Institute of Fundamental and Clinical Immunology

Email: vakoz40@yandex.ru

PhD, MD (Medicine), Professor, Full Member, Russian Academy of Sciences, Head, Laboratory of Clinical Immunopathology, Research Director, Research Institute of Fundamental and Clinical Immunology

Russian Federation, Novosibirsk

D. V. Vladimirovna

Research Institute of Fundamental and Clinical Immunology

Email: immunology@mail.ru

PhD (Medicine), Allergologist, Head, Department of Allergology, Research Institute of Fundamental and Clinical Immunology

Russian Federation, Novosibirsk

A. E. Sizikov

Research Institute of Fundamental and Clinical Immunology

Email: sizikovae@niikim.ru

PhD (Medicine), Rheumatologist, Head, Department of Rheumatology Research Institute of Fundamental and Clinical Immunology

Russian Federation, Novosibirsk

E. A. Pashkina

Research Institute of Fundamental and Clinical Immunology

Email: pashkina.e.a@yandex.ru

PhD (Biology), Senior Research Associate, Laboratory of Clinical Immunopathology, Research Institute of Fundamental and Clinical Immunology

Russian Federation, Novosibirsk

References

  1. Мерфи К., Уивер К. Иммунобиология по Джанвэю: пер. с англ.; под ред. Г.А. Игнатьевой, О.А. Свитич, И.Н. Дьякова. М.: Логосфера, 2020. 1184 с. [Murphy K., Weaver K. Janway Immunobiology. Transl. from English; ed. G.A. Ignatieva, O.A. Svitich, I.N. Dyakova]. Moscow: Logosfera, 2020. 1184 p.
  2. Carlini F., Picard C., Garulli C., Piquemal D., Roubertoux P., Chiaroni J., Chanez P., Gras D., di Cristofaro J. Bronchial epithelial cells from asthmatic patients display less functional HLA-G isoform expression. Front. Immunol., 2017, Vol. 8, 6. doi: 10.3389/fimmu.2017.00006.
  3. Coupel S., Moreau A., Hamidou M., Horejsi V., Soulillou J.P., Charreau B. Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood, 2007, Vol. 109, no. 7, pp. 2806-2814.
  4. Iwaszko M., Bogunia-Kubik K. Clinical significance of the HLA-E and CD94/NKG2 interaction. Arch. Immunol. Ther. Exp. (Warsz), 2011, Vol. 59, no. 5, pp. 353-367.
  5. Kochan G., Escors D., Breckpot K., Guerrero-Setas D. Role of non-classical MHC class I molecules in cancer immunosuppression. Oncoimmunology, 2013, Vol. 2, no. 11, e26491. doi: 10.4161/onci.26491.
  6. Kraemer T., Celik A.A., Huyton T., Kunze-Schumacher H., Blasczyk R., Bade-Döding C. HLA-E: Presentation of a broader peptide repertoire impacts the cellular immune response-implications on HSCT outcome. Stem Cells Int., 2015, Vol. 2015, 346714. doi: 10.1155/2015/346714.
  7. Leavenworth J.W., Wang X., Wenander C.S., Spee P., Cantor H. Mobilization of natural killer cells inhibits development of collagen-induced arthritis. Proc. Natl Acad. Sci. USA 2011, Vol. 108, no. 35, pp. 14584-14589.
  8. Lim R., Chan S.T., Tan J.L., Mockler J.C., Murphy S.V., Wallace E.M. Preterm human amnion epithelial cells have limited reparative potential. Placenta, 2013, Vol. 34, no. 6, pp. 486-492.
  9. Melén E., Kho A.T., Sharma S., Gaedigk R., Leeder J.S., Mariani T.J., Carey V.J., Weiss S.T., Tantisira K.G. Expression analysis of asthma candidate genes during human and murine lung development. Respir. Res., 2011, Vol. 12, no. 1, 86. doi: 10.1186/1465-9921-12-86.
  10. Morandi F., Pistoia V. Interactions between HLA-G and HLA-E in physiological and pathological conditions. Front. Immunol., 2014, Vol. 5, 394. doi: 10.3389/fimmu.2014.00394.
  11. Paech C., Albrecht V., Putke K., Schöfl G., Schöne B., Schmidt A.H., Lange V., Klussmeier A. HLA-E diversity unfolded: Identification and characterization of 170 novel HLA-E alleles. HLA, 2021, Vol. 97, no. 5, pp. 389-398.
  12. Sauter J., Putke K., Schefzyk D., Pruschke J., Solloch U.V., Bernas S.N., Massalski C., Daniel K., Klussmeier A., Hofmann J.A., Lange V., Schmidt A.H. HLA-E typing of more than 2.5 million potential hematopoietic stem cell donors: Methods and population-specific allele frequencies. Hum. Immunol., 2021, Vol. 82, no. 7, pp. 541-547.
  13. Wang X., Xiong H., Ning Z. Implications of NKG2A in immunity and immune-mediated diseases. Front. Immunol., 2022, Vol. 13, 960852. doi: 10.3389/fimmu.2022.960852.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Figure 1. Expression of HLA-E molecules on CD8+T cells in healthy donors and patients with bronchial asthma and rheumatoid arthritis

Download (61KB)
3. Figure 2. Expression of HLA-E molecules on CD4+T cells in healthy donors and patients with bronchial asthma and rheumatoid arthritis

Download (55KB)
4. Figure 3. Expression of HLA-E molecules on CD14+T cells in healthy donors and patients with bronchial asthma and rheumatoid arthritis

Download (49KB)

Copyright (c) 2023 Boeva O.S., Borisevich V.I., Kozlov V.A., Vladimirovna D.V., Sizikov A.E., Pashkina E.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).